1. Khademi, Bahareh, Khorrami, Mehdi, Ayromlou, Hormoz, Alizadeh-Ghodsi, Mohammadreza, Emamalizadeh, Babak. 2021. An interdependence between GAPVD1 gene polymorphism, expression level and response to interferon beta in patients with multiple sclerosis. In Journal of neuroimmunology, 353, 577507. doi:10.1016/j.jneuroim.2021.577507. https://pubmed.ncbi.nlm.nih.gov/33548618/
2. Hermle, Tobias, Schneider, Ronen, Schapiro, David, Shril, Shirlee, Hildebrandt, Friedhelm. 2018. GAPVD1 and ANKFY1 Mutations Implicate RAB5 Regulation in Nephrotic Syndrome. In Journal of the American Society of Nephrology : JASN, 29, 2123-2138. doi:10.1681/ASN.2017121312. https://pubmed.ncbi.nlm.nih.gov/29959197/
3. Wang, Lu, Zhang, Lifen, Luo, Pei, Zhao, Xinhan, Luo, Minna. 2024. GAPVD1 Promotes the Proliferation of Triple-Negative Breast Cancer Cells by Regulating the ERK/MAPK Signaling Pathway. In Current cancer drug targets, , . doi:10.2174/0115680096303983240616191051. https://pubmed.ncbi.nlm.nih.gov/39021189/
4. Sarath Babu, Nukala, Murthy, Ch Lakshmi N, Kakara, Sameera, Brahmendra Swamy, Cherukuvada V, Idris, Mohammed M. . 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced Parkinson's disease in zebrafish. In Proteomics, 16, 1407-20. doi:10.1002/pmic.201500291. https://pubmed.ncbi.nlm.nih.gov/26959078/